The humoral immune response of mice exposed to simulated road paving-like asphalt fumes

Journal of Immunotoxicology

Volumn 5, Issue 3, 2008, Pages 307-313

  Anderson, Stacey E ^a   Munson, Albert E ^a   Tomblyn, Seth ^a   Meade, B Jean ^a   Diotte, Nicole M ^b  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

Asphalt fumes; Immunotoxicity; Paving asphalt; PFC assay; SRBC

Indexed keywords

ASPHALT; IMMUNOGLOBULIN M; T LYMPHOCYTE ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPIRATION; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; FUME; HUMORAL IMMUNITY; IMMUNOTOXICITY; IN VIVO STUDY; INHALATION; MOUSE; NONHUMAN; PARTICULATE MATTER; PHARYNX; PRIORITY JOURNAL; SIMULATION; SKIN; SPLEEN;

ANIMALS; ANTIBODY FORMATION; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; ERYTHROCYTES; FEMALE; HYDROCARBONS; IMMUNIZATION; IMMUNOGLOBULIN M; INHALATION EXPOSURE; MICE; MICE, INBRED STRAINS; OCCUPATIONAL EXPOSURE; SHEEP; SMOKE; SPLEEN;

MURINAE; MUS;

EID: 53149113399     PISSN: 1547691X     EISSN: 1547691X     Source Type: Journal    
DOI: 10.1080/15376510802312407     Document Type: Article

References (46)

1. Abruzzo, L. V., Mullen, C. A., and Rowley, D. A. 1986. Immunoregulation by natural killer cells. Cell. Immunol. 98:266-278.
2. AI (Asphalt Institute). 1990. Report to OSHA and NIOSH: Status of Asphalt Industry Steering Committee Research Program on the Health Effects of Asphalt Fumes and Recommendation for aWorker Health Standard. Lexington, KY: The Asphalt Institute.
3. AI (Asphalt Institute). 1991. Final Report: Asphalt Industry Cross-Sectional Exposure Assessment Study. Test and Appendix A. College Park, MD: The Asphalt Institute.
4. Anderson, S. E., Meade, B. J., and Munson, A. E. 2007. The humoral immune response of mice exposed to manual metal arc stainless steel welding fumes. J. Immunotoxicol. 4:15-23.
5. Anderson, S. E., Munson, A. E., and Meade, B. J. 2006. Analysis of immunotoxicity by enumeration of antibody-producing B-cells. In: Current Protocols in Toxicology (Bus, J. S., Costa, L. G., Hodgson, E., Lawrence, D. A., and Reed, D., Eds.), Wiley Interscience: Hoboken, NJ, Section 18:11.
6. Antonini, J. M., Roberts, J. R., Taylor, M. D., Yin, X., Stone, S., Moseley, A., Ma, J. K., Frazer, D. G., Castranova, V., and Ma, J. Y. 2003. Effect of asphalt fume inhalation exposure at simulated road paving conditions prior to bacterial infection on lung defense responses in rats. Inhal. Toxicol. 15:1347-1368.
7. Bender, A. P., Parker, D. L., Johnson, R. A., Scharber, W. K., Williams, A. N., Marbury, M. C., and Mandel, J. S. 1989. Minnesota highway maintenance worker study: Cancer mortality. Am. J. Ind. Med. 15:545-556.
8. Blanton, R. H., Lyte, M., Myers, M. J., and Bick, P. H. 1986. Immunomodulation by polyaromatic hydrocarbons in mice and murice cells. Cancer Res. 46:2735-2739.
9. Buratti, M., Campo, L., Fustinoni, S., Cirla, P. E., Martinotti, I., Cavallo, D., and Foa, V. 2007. Urinary hydroxylated metabolites of polycyclic aromatic hydrocarbons as biomarkers of exposure in asphalt workers. Biomarkers 12:221-239.
10. Burchiel, S. W., and Luster, M. I. 2001. Signaling by environmental polycyclic aromatic hydrocarbons in human lymphocytes. Clin. Immunol. 98:2-10.
11. Campo, L., Buratti, M., Fustinoni, S., Cirla, P. E., Martinotti, I., Longhi, O., Cavallo, D., and Foa, V. 2006. Evaluation of exposure to PAHs in asphalt workers by environmental and biological monitoring. Ann. N. Y. Acad. Sci. 1076:405-420.
12. Carlson, E. A., Li, Y., and Zelikoff, J. T. 2004. Suppressive effects of benzo[a]pyrene upon fish immune function: Evolutionarily-conserved cellular mechanisms of immunotoxicity. Mar. Environ. Res. 58:731-734.
13. Davila, D. R., Mounho, B. J., and Burchiel, S. W. 1997. Toxicity of polycyclic aromatic hydrocarbons to the human immune system: Models and mechanisms. Toxicol. Ecotoxicol. News 4:5-9.
14. Dunnett, C. W., and Crisafio, R. 1955. The operating characteristics of some official weight variation tests for tablets. J. Pharm. Pharmacol. 7:314-327.
15. Engholm, G., Englung, A., and Linder, B. 1991. Mortality and cancer incidence in Swedish road paving asphaltworkers and roofers. Health Environ. 1:62-68.
16. EPA 2003. National Emission Standards for Hazardous Air Pollutants: Asphalt Processing and Asphalt Roofing Manufacturing. Washington D.C., EPA-453/R-03-005.
17. Gamble, J. F., Nicolich, M. J., Barone, N. J., and Vincent, W. J. 1999. Exposure-response of asphalt fumes with changes in pulmonary function and symptoms. Scand. J. Work Environ. Health 25:186-206.
18. Gao, J., Lauer, F. T., Dunaway, S., and Burchiel, S. W. 2005. Cytochrome P450 1B1 is required for 7,12-dimethylbenz(a)-anthracene(DMBA) induced spleen cell immunotoxicity. Toxicol. Sci. 86:68-74.
19. Grove, A. D., Llewellyn, G. C., Kessler, F. K., White, K. L., Jr., Crespi, C. L., and Ritter, J. K. 2000. Differential protection by rat UDP-glucuronosyltransferase 1A7 against benzo[a]pyrene-3,6-quinone- vs. benzo[a]pyrene-induced cytotoxic effects in human lymphoblastoid cells. Toxicol. Appl. Pharmacol. 162:34-43.
20. Hansen, E. S. 1989. Cancer incidence in an occupational cohort exposed to bitumen fumes. Scand. J. Work Environ. Health 15:101-105.
21. Hansen, E. S. 1991. Mortality of mastic asphaltworkers. Scand. J. Work Environ. Health 17:20-24.
22. Hicks, J. B. 1995. Asphalt industry cross-sectional exposure assessment study. Appl. Occup. Environ. Hyg. 10:840-848.
23. Jarvholm, B. 2006. Carcinogens in the construction industry. Ann. N. Y. Acad. Sci. 1076:421-428.
24. Jerne, N. K., and Nordin, A. A. 1963. Plaque formation in agar by single antibody-producing cells. Science 140:405.
25. Knecht, U., andWoitowitz, H. J. 1989. Risk of cancer from the use of tar bitumen in road works. Br. J. Ind. Med. 46:24-30.
26. Law, B. F., Stone, S., Frazer, D., and Siegel, P. D. 2006. Characterization of laboratory simulated road paving-like asphalt by high-performance liquid chromatography and gas chromatography-mass spectrometry. J. Occup. Environ. Hyg. 3:343-350.
27. Levin, J. O., Andersson, K., and Hallgren, C. 1994. Exposure to low molecular polyamines during road paving. Ann. Occup. Hyg. 38:257-264.
28. Luster, M. I., Munson A. E., Thomas P. T., Holapple, M. P., Fenter, J. D., White, Jr., K. L., Lauer, L. D., Germolec, D. R., Rosenthal, G. J., and Dean, J. H. 1988. Development of a testing battery to assess chemical-induced immunotoxicity: National Toxicology Program's guidelines for immunotoxicity evaluated in mice. Fundam. Appl. Toxicol. 10:2-19.
29. Ma, J. Y., Rengasamy, A., Frazer, D., Barger, M. W., Hubbs, A. F., Battelli, L., Tomblyn, S., Stone, S., and Castranova, V. 2003. Inhalation exposure of rats to asphalt fumes generated at paving temperatures alters pulmonary xenobiotic metabolism pathways without lung injury. Environ. Health Perspect. 111:1215-1221.
30. Ma, J. Y., Yang, H. M., Barger, M. W., Siegel, P. D., Zhong, B. Z., Kriech, A. J., and Castranova, V. 2002. Alteration of pulmonary cytochrome P450 system: Effects of asphalt fume condensate exposure. J. Toxicol. Environ. Health 65:1247-1260.
31. Machado, M. L., Beatty, P. W., Fetzer, J. C., Glickman, A. H., and McGinnis, E. L. 1993. Evaluation of the relationship between PAH content and mutagenic activity of fumes form roofing and paving asphalts and coal tar pitch. Fundam. Appl. Toxicol. 21:492-499.
32. Maizlish, N., Beaumont, J., and Singleton, J. 1988. Mortality among California highway workers. Am. J. Ind. Med. 13:363-379.
33. McClean, M. D., Rinehart, R. D., Ngo, L., Eisen, E. A., Kelsey, K. T., and Herrick, R. F. 2004. Inhalation and dermal exposure among asphalt paving workers. Ann. Occup. Hyg. 48:663-671.
34. Myers, M. J., Schook, L. B., and Bick, P. H. 1987. Mechanisms of benzo(a)pyrene-induced modulation of antigen presentation. J. Pharmacol. Exp. Ther. 242:399-404.
35. NIOSH. 2003. Asphalt fume exposures during the application of hot asphalt to roofs. Current practices for reducing exposure. In: Department of Health and Human Services NIOSH Publication No. 2003-112. NIOSH: Cincinnati, OH.
36. Norseth, T., Waage, J., and Dale, I. 1991. Acute effects and exposure to organic compounds in road maintenance workers exposed to asphalt. Am. J. Ind. Med. 20:737-744.
37. H2 proliferation by IFN-γ involves interference with IL-1. J. Immunol. 158:3666-3672.
38. Partanen, T., and Boofetta, P. 1994. Cancer risk in asphalt workers and roofers: Review and meta-analysis of epidemiologic studies. Am. J. Ind. Med. 26:721-740.
39. Rao, G. V., Tinkle, S., Weissman, D. N., Antonini, J. M., Kashon, M. L., Salmen, R., Battelli, L. A., Willard, P. A., Hoover, M. D., and Hubbs, A. F. 2003. Efficacy of a technique for exposing the mouse lung to particles aspirated from the pharynx. J. Toxicol. Environ. Health 66:1441-1452.
40. Robles, C. P., and Pollack, S. B. 1986. Antibody responses and regulation. A role for natural killer cells. Nat. Immun. Cell Growth Regul. 5:64-74.
41. Speight, J. G. 1992. Asphalt. In: Kirk-Othmer Encyclopedia of Chemical Technology, 4th Edition, Volume 3 (Kroschwitz J. L., Howe-Grant M, Eds.), Wiley Interscience: New York, pp. 689-724.
42. Tewari, R. P., Balint, J. P., and Brown K. A. 1979. Suppressive effect of 3-methylcho-lanthrene on phagocytic activity of mouse peritoneal macrophages for Torulopsis glabrata. J. Natl. Cancer Inst. 62:983-988.
43. 2.5 particles for road paving workers applying conventional asphalt and crumb rubber modified asphalt. J. Exposure Anal. Environ. Epidemiol. 8:213-229.
44. White, K. L., Jr., and Holsapple, M. P. 1984. Direct suppression of in vitro antibody production by mouse spleen cells by the carcinogen benzo(a)pyrene but not by the noncarcinogenic congener benzo(e)pyrene. Cancer Res. 44:3388-3393.
45. Wolff, M. S., Herbert, R., Marcus, M., Rivera, M., Landrigan, P. J., and Andrews, L. R. 1989. Polycyclic aromatic hydrocarbon (PAH) residues on skin in relation to air levels among roofers. Arch. Environ. Health 44: 157-163.
46. Woods, G. M., Doherty, K. V., Malley, R. C., Rist, M. J., and Muller, H. K. 2000. Carcinogen-modified dendritic cells induce immunosuppression by incomplete T-cell activation resulting from impaired antigen uptake and reduced CD86 expression. Immunology 99:16-22.